Bilaketaren emaitzak - Anette Torvin Møller
- Erakusten 1 - 5 emaitzak -- 5
-
1
Reproducibility, and sensitivity to motor unit loss in amyotrophic lateral sclerosis, of a novel MUNE method: MScanFit MUNE nork Anna Bystrup Jacobsen, Hugh Bostock, Anders Fuglsang‐Frederiksen, Lene Duez, Sándor Beniczky, Anette Torvin Møller, Jakob Udby Blicher, Hatice Tankişi
Argitaratua 2017Artigo -
2
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel nork Alessandro P Burlina, Katherine B. Sims, Juan Politei, Gary J. Bennett, Ralf Baron, Claudia Sommer, Anette Torvin Møller, Max J. Hilz
Argitaratua 2011Revisão -
3
Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study nork Anne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, Anders Hedegaard Jessen, Anne Øberg Lauritsen, Stephen Wørlich Pedersen, Kirsten Svenstrup, Merete Karlsborg, Helle Thagesen, Morten Blaabjerg, Ásta Theódórsdóttir, Elisabeth Gundtoft Elmo, Anette Torvin Møller, Lone Bonefeld, M. van den Berg, Peter Garred, Kirsten Møller
Argitaratua 2021Artigo -
4
Haplotypes and gene expression implicate the <i>MAPT</i> region for Parkinson disease nork Jennifer E. Tobin, Jeanne C. Latourelle, Mark Lew, Christine Klein, Oksana Suchowersky, H. A. Shill, Lawrence I. Golbe, M. H. Mark, John H. Growdon, G. Frederick Wooten, Brad A. Racette, J. S. Perlmutter, Ray L. Watts, Mark Guttman, Kenneth B. Baker, Stefano Goldwurm, Gianni Pezzoli, Carlos Singer, Marie Saint‐Hilaire, Audrey E. Hendricks, Sally Williamson, Michael W. Nagle, Jemma B. Wilk, Tiffany Massood, Jason M. Laramie, Anita L. DeStefano, Irene Litvan, Garth A. Nicholson, Alastair Corbett, Stuart Isaacson, David J. Burn, Patrick F. Chinnery, Peter P. Pramstaller, Scott J. Sherman, Jomana T. Al‐Hinti, Edward Drasby, Martha Nance, Anette Torvin Møller, Karen Østergaard, Richard Roxburgh, B. J. Snow, John T. Slevin, Franca Cambi, James F. Gusella, Richard H. Myers
Argitaratua 2008Artigo -
5
The Gly2019Ser mutation in LRRK2is not fully penetrant in familial Parkinson's disease: the GenePD study nork Jeanne C. Latourelle, Mei Sun, Mark Lew, Oksana Suchowersky, Christine Klein, Lawrence I. Golbe, Margery H. Mark, John H. Growdon, G. Frederick Wooten, Ray L. Watts, Mark Guttman, Brad A. Racette, Joel S. Perlmutter, Anwar Ahmed, Holly A. Shill, Carlos Singer, Stefano Goldwurm, Gianni Pezzoli, Michela Zini, Marie Saint‐Hilaire, Audrey E. Hendricks, Sally Williamson, Michael W. Nagle, Jemma B. Wilk, Tiffany Massood, Karen W. Huskey, Jason M. Laramie, Anita L. DeStefano, Kenneth B. Baker, Ilia Itin, Irene Litvan, Garth A. Nicholson, Alastair Corbett, Martha Nance, Edward Drasby, Stuart Isaacson, David J. Burn, Patrick F. Chinnery, Peter P. Pramstaller, Jomana T. Al‐Hinti, Anette Torvin Møller, Karen Østergaard, Scott J. Sherman, Richard Roxburgh, Barry Snow, John T. Slevin, Franca Cambi, James F. Gusella, Richard H. Myers
Argitaratua 2008Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Disease
Medicine
Internal medicine
Amyotrophic lateral sclerosis
Biology
Gene
Genetics
Neurology
Parkinson's disease
Pathology
Psychiatry
Allele
Anatomy
Anesthesia
Area under the curve
Chemistry
Chromatography
Coefficient of variation
Cohort
Cohort study
Danish
Diabetes mellitus
Endocrinology
Enzyme replacement therapy
Fabry disease
Globotriaosylceramide
Haplotype
Intensive care medicine
LRRK2
Linguistics